Samtidig brug af cytotoksiske lægemidler kan nedsætte absorptionen af fenytoin og dermed føre til øget hyppighed af kramper.
This risk is increased in subjects who are already immunosuppressed by their underlying disease Phenytoin: concomitant use of cytotoxic medicinal products may reduce the absorption of phenytoin leading to an exacerbation of convulsions.